Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology-Reference-Cited by-同舟云学术

Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology

Published:2022-09-19 Issue: Volume: Page:
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Cohen Philip R.,Kurzrock Razelle

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-022-00801-2.pdf

Reference107 articles.

1. Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86: 102019. https://doi.org/10.1016/j.ctrv.2020.102019.

2. Adashek JJ, Subbiah V, Kurzrock R. From tissue-agnostic to N-of-one therapies: (r)evolution of the precision paradigm. Trends Cancer. 2021;7(1):15–28. https://doi.org/10.1016/j.trecan.2020.08.009.

3. Adashek JJ, Goloubev A, Kato S, Kurzrock R. Missing the target in cancer therapy. Nat Cancer. 2021;2:369–71. https://doi.org/10.1038/s43018-021-00204-w.

4. Moser C, Lerche CJ, Thomsen K, et al. Antibiotic therapy as personalized medicine—general considerations and complicating factors. APMIS. 2019;127(5):361–71. https://doi.org/10.1111/apm.12951.

5. Rosenblatt JE. Laboratory tests used to guide antimicrobial therapy. Mayo Clin Proc. 1991;66(9):942–8. https://doi.org/10.1016/s0025-6196(12)61583-3.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point;Pharmacopsychiatry;2024-08-19

2. Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation;International Journal of Molecular Sciences;2024-04-19

3. Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa;Current Drug Targets;2024-04

4. MOLECULAR TARGETED THERAPIES FOR CUTANEOUS SQUAMOUS CELL CARCINOMA: RECENT DEVELOPMENTS AND CLINICAL IMPLICATIONS;EXCLI J;2024

5. Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?;Clinical & Experimental Metastasis;2023-12-08